Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 3Terminated 1

Sponsor Class

OTHER 6INDUSTRY 4NIH 2NETWORK 2

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Genitourinary 3Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 3Erectile Dysfunction 1Dermatitis, Seborrheic 1Alopecia 1Adenocarcinoma 1Acne Vulgaris 1

Interventions

pembrolizumab 1029Carboplatin 966Paclitaxel 941Gemcitabine 798Cisplatin 754Docetaxel 697Bevacizumab 638Nivolumab 519Pemetrexed 507Capecitabine 475Cyclophosphamide 468Fluorouracil 424Dexamethasone 409Rituximab 391Oxaliplatin 351Injections 344Trastuzumab 313atezolizumab 311Cetuximab 291Leucovorin 288Irinotecan 269130-nm albumin-bound paclitaxel 255Prednisone 250Ipilimumab 244Doxorubicin 241Lenalidomide 231Fulvestrant 226fludarabine 215durvalumab 211Erlotinib Hydrochloride 196

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Cyproterone Acetate × Clear all
NCT04925180 2022-01-12

Safe-CAM

Bayer

Completed
600 enrolled
Genitourinary

Acne Vulgaris, Alopecia, Prostatic Neoplasms, Dermatitis, Seborrheic

NCT01011751 2015-07-30

Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma

Takeda

Phase 3 Completed
311 enrolled
Tumor-Agnostic

Adenocarcinoma

NCT00919022 2012-11-01

ANES

Bayer

Terminated
194 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

NCT00908674 2010-04-13

Androcur Effects on Quality of Life

Bayer

Completed
245 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡